In rat adjuvant-induced arthritis (AIA), CCL5 levels peak before disease onset but CCL2 levels only rise once joint inflammation is fully established. Outcomes of CCL2 or CCL5 blockade are thought ...
Coya Therapeutics' Phase 2 study shows monthly LD IL-2 improves cognitive scores and reduces inflammation in Alzheimer's patients, with no serious adverse events.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback